spacer
home > pmps > summer 2019 > the end of the automation pyramid
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The End of the Automation Pyramid

With structures over four thousand years old, Egypt boasts some of the oldest pyramids in existence. However, the history of automation’s pyramid, a diagram representing the integration of technologies, dwarfs in comparison. Could this engineering concept be coming to an end?

As a pictorial example of the different levels of automation in a factory, the automation pyramid has long been used as a visual aid to understand how layers of technology communicate.

Starting from process and field levels and working up to the corporate level of manufacturing processes, the traditional pyramid illustrates how devices, actuators, and sensors on the factory floor are distinctly separate from other areas such as process control, supervisory networks, and enterprise systems.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stefan Reuther is an Industrial Engineer and holds a degree in Law and Economics from the Paris Lodron University of Salzburg, Austria. Since the beginning of 2017, he has been part of the Executive Board and Chief Sales Officer at COPA-DATA in Salzburg. He is in charge of sales and business development for the entire COPA-DATA group. His extensive experience in industrial automation, strategic management, and law helps him ensure the company meets its target growth trajectory.
spacer
Stefan Reuther
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Hansa Biopharma initiate a new Contract Development and Manufacturing project in immunological diseases

Vilnius, Lithuania, and Lund, Sweden - December 20th, 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced a new service agreement to develop the next generation of IgG cleaving enzymes.
More info >>

White Papers

Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?

Clinical Professionals

Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >>

 
Industry Events

Pharmapack Europe 2020

5-6 February 2020, Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement